Affiliation:
1. Global Biostatistics and Data Sciences Boehringer Ingelheim Pharma GmbH & Co. KG Ingelheim Germany
2. Department of Pharmacy Uppsala University Uppsala Sweden
3. Global Biostatistics and Data Sciences Boehringer Ingelheim Pharmaceuticals Inc. Ridgefield Connecticut USA
4. Merck & Co., Inc. Rahway New Jersey USA
5. Novartis Pharmaceuticals Corporation East Hanover New Jersey USA
Abstract
In a multi‐center randomized controlled trial (RCT) with competitive recruitment, eligible patients are enrolled sequentially by different study centers and are randomized to treatment groups using the chosen randomization method. Given the stochastic nature of the recruitment process, some centers may enroll more patients than others, and in some instances, a center may enroll multiple patients in a row, for example, on a given day. If the study is open‐label, the investigators might be able to make intelligent guesses on upcoming treatment assignments in the randomization sequence, even if the trial is centrally randomized and not stratified by center. In this paper, we use enrollment data inspired by a real multi‐center RCT to quantify the susceptibility of two restricted randomization procedures, the permuted block design and the big stick design, to selection bias under the convergence strategy of Blackwell and Hodges (1957) applied at the center level. We provide simulation evidence that the expected proportion of correct guesses may be greater than 50% (i.e., an increased risk of selection bias) and depends on the chosen randomization method and the number of study patients recruited by a given center that takes consecutive positions on the central allocation schedule. We propose some strategies for ensuring stronger encryption of the randomization sequence to mitigate the risk of selection bias.
Reference12 articles.
1. Properties of permuted-block randomization in clinical trials
2. AnisimovV.Predictive Modelling of Recruitment and Drug Supply in Multicenter Clinical Trials. Proceedings of the Joint Statistical Meetings. Washington DC: JSM.20091248‐1259.
3. Drug supply modelling in clinical trials (statistical methodology);Anisimov V;Pharmaceut Outsourc,2010
4. Selecting a randomization method for a multi‐center clinical trial with stochastic recruitment considerations;Sverdlov O;BMC Med Res Methodol,2024
5. Modelling, prediction and adaptive adjustment of recruitment in multicentre trials